Summary of Key Information:
Reporting Period (Quarter/Year): Not Applicable
Nature of Filing / Announcement: Outcome of Board Meeting regarding allotment of equity shares pursuant to warrant conversion
Audit Opinion:
Not Specified
Key Financial Highlights:
The document does not contain financial results (Revenue, EBITDA, Net Profit, etc.) for any reporting period.
Corporate Actions:
Warrant Conversion and Equity Allotment:
- The Board approved the allotment of 18,19,800 (Eighteen Lakh Nineteen Thousand Eight Hundred) fully paid-up equity shares of face value ₹10 each
- This allotment results from the conversion of convertible warrants originally issued on a preferential basis
- The warrants were originally allotted on 17th January, 2025 at an issue price of ₹216 per warrant
- Each warrant was convertible into one fully paid-up equity share upon payment of the balance 75% of the issue price
- The warrant entitlement was adjusted due to a 2:1 bonus issue approved by members on 14th October, 2025
Capital Structure Change:
- Existing paid-up capital: 3,59,86,770 equity shares
- Post-allotment paid-up capital: 3,78,06,570 equity shares
- Total funds raised through this conversion: ₹9,41,43,600.00 (from balance 75% consideration)
Unique Arrangement for Partial Payments:
- The Board decided not to forfeit the initial 25% consideration received from warrant holders who did not pay the balance 75% consideration
- Instead, the Board approved allotment of equity shares proportionate to the amount of consideration received from such warrant holders
- This arrangement is subject to applicable laws and regulatory approvals
Other Significant Information:
Company Background:
- ISO 9001:2015, 14001:2015, OHSAS 18001:2007 Certified Company
- GSTN No: 27AABCU0775C1ZJ
Authorization History:
- Board approval for warrant issuance: 26th September, 2024
- Shareholder approval: Extra-Ordinary General Meeting held on 23rd October, 2024
- In-principle approvals received from Stock Exchange(s)